EBITDA CAGR uses clean operating EBITDA derived from reported operating income plus depreciation and amortization.
Over longer horizons, EBITDA CAGR averages 14.52% over 3 years and 11.94% over 5 years; the trailing 12 months came in at +4.88%. EBITDA CAGR shows how the company's operating profitability has grown before depreciation and amortization. This reflects the growth of the core business's cash-operating earnings power, independent of capital-intensity and accounting depreciation choices.
Healthpeak Properties, Inc. (DOC)
EBITDA growth vs the same quarter one year earlier, last 40 quarters.
Reported quarterly EBITDA; no daily interpolation.
| Year | Start EBITDA | End EBITDA | Change | % Change |
|---|---|---|---|---|
| 2025 | $1.53B | $1.60B | +$74.57M | +4.88% |
| 2024 | $1.18B | $1.53B | +$344.62M | +29.11% |
| 2023 | $1.07B | $1.18B | +$116.66M | +10.93% |
| 2022 | $1.02B | $1.07B | +$42.55M | +4.15% |
| 2021 | $912.29M | $1.02B | +$112.31M | +12.31% |
| 2020 | $966.93M | $912.29M | −$54.64M | -5.65% |
| 2019 | $860.78M | $966.93M | +$106.15M | +12.33% |
| 2018 | $1.09B | $860.78M | −$232.58M | -21.27% |
| 2017 | $1.29B | $1.09B | −$193.93M | -15.06% |
| 2016 | $1.23B | $1.29B | +$53.44M | +4.33% |
| 2015 | $1.17B | $1.23B | +$60.07M | +5.12% |
| 2014 | $1.70B | $1.17B | −$524.78M | -30.90% |
| 2013 | $1.53B | $1.70B | +$167.71M | +10.96% |
| 2012 | $1.38B | $1.53B | +$151.18M | +10.96% |
| Quarter | Value | QoQ | YoY |
|---|---|---|---|
| Quarter ended Jun 2026 | $408.25M | +0.4% | +2.7% |
| Quarter ended Mar 2026 | $406.77M | -0.3% | +0.8% |
| Quarter ended Dec 2025 | $407.92M | +3.5% | +2.7% |
| Quarter ended Sep 2025 | $394.04M | -0.8% | -0.7% |
| Quarter ended Jun 2025 | $397.40M | -1.5% | +0.6% |
| Quarter ended Mar 2025 | $403.63M | +1.7% | +18.9% |
| Quarter ended Dec 2024 | $397.03M | +0.0% | +29.0% |
| Quarter ended Sep 2024 | $396.90M | +0.5% | +32.1% |
| Quarter ended Jun 2024 | $394.96M | +16.3% | +32.7% |
| Quarter ended Mar 2024 | $339.53M | +10.3% | +22.1% |
| Quarter ended Dec 2023 | $307.69M | +2.4% | +25.0% |
| Quarter ended Sep 2023 | $300.42M | +0.9% | +9.0% |
| Quarter ended Jun 2023 | $297.66M | +7.1% | +7.0% |
| Quarter ended Mar 2023 | $278.04M | +13.0% | +4.0% |
| Quarter ended Dec 2022 | $246.10M | -10.7% | -4.6% |
| Quarter ended Sep 2022 | $275.65M | -0.9% | +7.7% |
QoQ = change vs the prior quarter; YoY = change vs the same quarter a year earlier.
